Skip to main content
TipRanks
Go Ultimate75% OFF

IQVIA Holdings (IQV) Revenue by Segment

1,105 Followers

Revenue by Segment

IQVIA Holdings reported revenue by segment of $4.43B in Q3 2026, up 1.4% from Q2 2026 and up 8.0% year over year. This is the highest value since 2020.

Analyzes revenue from different business segments, highlighting which areas are driving growth and which may need strategic adjustments.

$0.00$1.00B$2.00B$3.00B$4.00BMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

IQVIA’s growth engine is shifting toward Research and Development Solutions, which has accelerated steadily and aligns with record clinical bookings, stronger win rates, and rising trial activity. The apparent emergence of Commercial Solutions in 2026 likely reflects a reporting reclassification rather than entirely new revenue, making historical segment comparisons unreliable; nevertheless, management confirmed nearly 8% constant-currency growth and broad-based momentum in commercial offerings. Technology and Analytics also reached a new high before its apparent reallocation, while Contract Sales and Medical Solutions remain comparatively modest. AI adoption could further support commercial growth and future margins.

IQV Revenue by Segment

PeriodTechnology and Analytics SolutionsResearch and Development SolutionsContract Sales and Medical SolutionsCommercial SolutionsTotal
Q3 2026Sep 30, 2026$0.00$2.64B$0.00$1.79B$4.43B
Q2 2026Jun 30, 2026$0.00$2.58B$0.00$1.79B$4.37B
Q1 2026Mar 31, 2026$0.00$2.40B$0.00$1.75B$4.15B
Q4 2025Dec 31, 2025$1.82B$2.33B$210.00M$0.00$4.36B
Q3 2025Sep 30, 2025$1.63B$2.26B$209.00M$0.00$4.10B
Q2 2025Jun 30, 2025$1.63B$2.20B$188.00M$0.00$4.02B
Q1 2025Mar 31, 2025$1.55B$2.10B$181.00M$0.00$3.83B
Q4 2024Dec 31, 2024$1.66B$2.12B$177.00M$0.00$3.96B
Q3 2024Sep 30, 2024$1.55B$2.16B$180.00M$0.00$3.90B
Q2 2024Jun 30, 2024$1.50B$2.15B$172.00M$0.00$3.81B
Q1 2024Mar 31, 2024$1.45B$2.10B$189.00M$0.00$3.74B
Q4 2023Dec 31, 2023$1.53B$2.15B$186.00M$0.00$3.87B
Q3 2023Sep 30, 2023$1.43B$2.12B$183.00M$0.00$3.74B
Q2 2023Jun 30, 2023$1.46B$2.10B$176.00M$0.00$3.73B
Q1 2023Mar 31, 2023$1.44B$2.03B$182.00M$0.00$3.65B
Q4 2022Dec 31, 2022$1.50B$2.06B$182.00M$0.00$3.74B
Q3 2022Sep 30, 2022$1.40B$1.98B$183.00M$0.00$3.56B
Q2 2022Jun 30, 2022$1.41B$1.95B$183.00M$0.00$3.54B
Q1 2022Mar 31, 2022$1.44B$1.93B$195.00M$0.00$3.57B
Q4 2021Dec 31, 2021$1.50B$1.94B$196.00M$0.00$3.64B
Q3 2021Sep 30, 2021$1.34B$1.85B$201.00M$0.00$3.39B
Q2 2021Jun 30, 2021$1.35B$1.89B$194.00M$0.00$3.44B
Q1 2021Mar 31, 2021$1.35B$1.87B$193.00M$0.00$3.41B
Q4 2020Dec 31, 2020$1.43B$1.68B$189.00M$0.00$3.30B
Q3 2020Sep 30, 2020$1.21B$1.40B$179.00M$0.00$2.79B
Q2 2020Jun 30, 2020$1.11B$1.24B$177.00M$0.00$2.52B
Q1 2020Mar 31, 2020$1.12B$1.44B$196.00M$0.00$2.75B

Related KPIs